Details for Patent: 11,596,634
✉ Email this page to a colleague
Which drugs does patent 11,596,634 protect, and when does it expire?
Patent 11,596,634 protects SUBVENITE and is included in one NDA.
Summary for Patent: 11,596,634
| Title: | Lamotrigine oral liquid suspension and use thereof |
| Abstract: | The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration. |
| Inventor(s): | Paul Sudhakar, Scott Boyer |
| Assignee: | OWP Pharmaceuticals Inc |
| Application Number: | US15/929,929 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 11,596,634
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Owp Pharms | SUBVENITE | lamotrigine | SUSPENSION;ORAL | 218879-001 | Sep 16, 2025 | RX | Yes | Yes | 11,596,634 | ⤷ Start Trial | ADJUNCTIVE THERAPY FOR PARTIAL-ONSET, PRIMARY GENERALIZED TONIC-CLONIC (PGTC), OR LENNOX-GASTAUT SEIZURES IN PATIENTS 2 YEARS AND OLDER | ⤷ Start Trial | ||||
| Owp Pharms | SUBVENITE | lamotrigine | SUSPENSION;ORAL | 218879-001 | Sep 16, 2025 | RX | Yes | Yes | 11,596,634 | ⤷ Start Trial | MAINTENANCE TREATMENT OF BIPOLAR I DISORDER TO DELAY MOOD EPISODES | ⤷ Start Trial | ||||
| Owp Pharms | SUBVENITE | lamotrigine | SUSPENSION;ORAL | 218879-001 | Sep 16, 2025 | RX | Yes | Yes | 11,596,634 | ⤷ Start Trial | CONVERSION TO MONOTHERAPY FOR PARTIAL-ONSET SEIZURES IN PATIENTS 16 YEARS AND OLDER | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
